KimW,ParkS,ChoiC,KimYR,ParkI,SeoC, 2016.Evaluation of anti-inflammatory potential of the new Ganghwaljetongyeum on adjuvant-induced inflammatory arthritis in rats,Evid Based Complement Alternat Med 1230294 -
ZhengC-J,ZhaoX-X,Ai H-W , Lin B,HanT,JiangY-P, 2014.Therapeutic effects of standardized Vitex negundo seeds extract on complete Freund's adjuvant induced arthritis in rats,Phytomed 21 838 -46
SukketsiriW,ChonpathompikunlertP,TanasawetS,ChoosriN,WongtawatchaiT., 2016.Effects of Apium graveolens extract on the oxidative stress in the liver of adjuvant-induced arthritic rats,Prev Nutr Food Sci 21 79 -84
WeiZF,JiaoXL,WangT,LuQ,XiaYF,WangZT, 2013.Norisoboldine alleviates joint destruction in rats with adjuvant-induced arthritis by reducing RANKL, IL-6, PGE2, and MMP-13 expression,Acta Pharmacol Sin 34 403 -13
AdeneyeAA,OreagbaAI,IsholaIO,KalejaiyeHA, 2014.Evaluation of the anti-arthritic activity of the hydroethanolic leaf extract of Alchornea cordifolia in rats,Afr J Tradit Complement Altern Med 11 402 -10
Rong-junHE,Zhi-hongYU,ZhangR, 2014.Protein tyrosine phosphatases as potential therapeutic targets,Acta Pharmacol Sin 35 1227 -46
SchellerJ,ChalarisA,GarbersC,Rose-John S, 2011.a molecular switch to control inflammation and tissue regeneration,Trends in Immunol 32 380 -7
Rose-JohnS., 2013.ADAM17 shedding, TACE as therapeutic targets,Pharmacol Res 71 19 -22
KimS,ChenZ,ChamberlainND,VolinMV,SwedlerW,VolkovS, 2013.Angiogenesis in rheumatoid arthritis is directly fostered by TLR5 ligation and indirectly through IL-17 induction,Arthritis Rheum 65 2024 -36
KimS,ChenZ,ChamberlainND,EssaniAB,VolinMV,AminMA, 2014.Ligation of TLR5 promotes myeloid cell infiltration and differentiation into mature osteoclasts in rheumatoid arthritis and experimental arthritis,J Immunol 193 3902 -13
HamaguchiM,KawahitoY,IshinoH,TakeuchiN,TokunagaD,HojoT, 2011.Mucin from rheumatoid arthritis synovial fluid enhances interleukin-6 production by human peripheral blood mononuclear cells,Human Immunol 72 241 -8
MorandEF,LeechM,BernhagenJ. MIF:, 2006.a new cytokine link between rheumatoid arthritis and atherosclerosis,Nat Rev Drug Discov 5 399 -410
KasamaT,OhtsukaK,SatoM,TakahashiR,WakabayashiK,KobayashiK., 2010.Macrophage migration inhibitory factor: A multifunctional cytokine in rheumatic diseases,Arthritis 106202 -
AugerI,CharpinC,BalandraudN,MartinM,RoudierJ, 2012.Autoantibodies to PAD4 and BRAF in rheumatoid arthritis,Autoimmun Rev 11 801 -3
ShodaH,FujioK,ShibuyaM,OkamuraT,SumitomoS,OkamotoA, 2011.Detection of autoantibodies to citrullinated BiP in rheumatoid arthritis patients and pro-inflammatory role of citrullinated BiP in collagen-induced arthritis,Arthritis Res Ther 13 R191 -
KhandpurR,Carmona-RiveraC,VivekanandanGiriA,GizinskiA,YalavarthiS,KnightJS, 2013.NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis,Sci Transl Med 5 178ra40 -
RabquerBJ,KochAE., 2013.NK4 therapy: a new approach to target angiogenesis and inflammation in rheumatoid arthritis,Arthritis Res Ther 15 119 -
RomeroV,Fert-BoberJ,NigrovicPA,DarrahE,HaqueUJ,LeeDM, 2013.Immune-mediated poreforming pathways induce cellular hypercitrullination and generate citrullinated autoantigens in rheumatoid arthritis,Sci Transl Med 5 209ra150 -
WalleLV,OpdenboschNV,JacquesP,FossoulA,VerheugenE,VogelP, 2014.Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis,Nature 512 69 -73
ChenS,SunB, 2013.Negative regulation of NLRP3 inflammasome signaling,Protein Cell 4 251 -8
SoA,BussoN., 2014.The concept of the inflammasome and its rheumatologic implications,Joint Bone Spine 81 398 -402
MidwoodK,SacreS,PiccininiAM,InglisJ,TrebaulA,ChanE, 2009.Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease,Nat Med 15 774 -81
RuhmannM,PiccininiAM,KongPL,MidwoodKS, 2012.Endogenous activation of adaptive immunity. Tenascin-C drives interleukin-17 synthesis in murine arthritic joint disease,Arthritis Rheum 64 2179 -90
ChenX,OppenheimJJ,HowardOMZ, 2004.Chemokines and chemokine receptors as novel therapeutic targets in rheumatoid arthritis (RA): Inhibitory effects of traditional Chinese medicinal components,Cell Mol Immunol 1 336 -42
ShadidiKR, 2004.New drug targets in rheumatoid arthritis focus on chemokines,Biodrugs 18 181 -7
SzekaneczZ,PakozdiA,SzentpeteryA,BesenyeiT,KochAE, 2010.Chemokines and angiogenesis in rheumatoid arthritis,Front Biosci (Elite Ed) 1 44 -51
IssureePDA,MaretzkyT,McIlwainDR,MonetteS,QingX,LangPA, 2013.iRHOM2 is a critical pathogenic mediator of inflammatory arthritis,J Clin Invest 123 928 -32
LichtenthalerSF, 2013.iRHOM2 takes control of rheumatoid arthritis,J Clin Invest 123 560 -2
TangW,LuY,TianQY,ZhangY,GuoFJ,LiuGY, 2011.The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice,Science 332 478 -84
2011.Progranulin: A promising therapeutic target for rheumatoid arthritis,FEBS Lett 585 3675 -80
Diaz-GalloLM,MartinJ., 2012.PTPN22 splice forms: a new role in rheumatoid arthritis,Genome Med 4 13 -
BurnGL,SvenssonL,Sanchez-BlancoC,SainiM,CopeAP, 2011.Why is PTPN22 a good candidate susceptibility gene for autoimmune disease,FEBS Lett 585 3689 -98